NB
BIO icon

Norinchukin Bank’s Bio-Rad Laboratories Class A BIO Stock Holding History

Norinchukin Bank’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-693
Closed -$240K – 543
2024
Q1 		$240K Sell
693
-7
-1% -$2.3K 0.01% 530
2023
Q4 		$226K Sell
700
-25
-3% -$7.84K 0.01% 537
2023
Q3 		$260K Sell
725
-249
-26% -$96.1K 0.01% 521
2023
Q2 		$369K Sell
974
-280
-22% -$114K 0.01% 520
2023
Q1 		$601K Buy
1,254
+43
+4% +$20.1K 0.01% 466
2022
Q4 		$509K Sell
1,211
-212
-15% -$85.6K 0.01% 475
2022
Q3 		$594K Buy
1,423
+116
+9% +$57.8K 0.01% 456
2022
Q2 		$647K Sell
1,307
-663
-34% -$345K 0.01% 447
2022
Q1 		$1.11M Buy
1,970
+150
+8% +$90.4K 0.01% 437
2021
Q4 		$1.38M Sell
1,820
-12
-0.7% -$8.98K 0.02% 388
2021
Q3 		$1.37M Buy
1,832
+48
+3% +$36K 0.02% 379
2021
Q2 		$1.15M Sell
1,784
-8
-0.4% -$4.87K 0.02% 401
2021
Q1 		$1.02M Buy
1,792
+28
+2% +$16.6K 0.01% 418
2020
Q4 		$1.03M Sell
1,764
-30
-2% -$17.1K 0.01% 385
2020
Q3 		$925K Buy
1,794
+24
+1% +$12.2K 0.01% 377
2020
Q2 		$799K Buy
+1,770
New +$781K 0.01% 384

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Norinchukin Bank's BIO Position: Q2 2024 in Review

Norinchukin Bank sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2024, closing a stake of 693 shares — an estimated $240K sold.

Norinchukin Bank first reported a position in BIO in Q2 2020 and held it in 16 quarters. The position peaked at $1.38M in Q4 2021. 440 funds tracked by Wall St. Rank hold BIO as of Q2 2024.

  • Norinchukin Bank reported no remaining Bio-Rad Laboratories Class A position as of Q2 2024 after selling out during the quarter.
  • Norinchukin Bank sold 693 Bio-Rad Laboratories Class A shares in Q2 2024, an estimated $240K.
  • Norinchukin Bank first reported a position in Bio-Rad Laboratories Class A in Q2 2020 and held it in 16 quarters.
  • Norinchukin Bank's Bio-Rad Laboratories Class A position peaked at $1.38M in Q4 2021.
  • 440 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2024.

Based on Norinchukin Bank's 13F filing for Q2 2024, filed 14 Aug 2024.